All Industries

Top Healthcare Companies

6,371 Healthcare companies, sorted by total funding raised.

InvivydIPO

Biotechnology company developing antibody-based therapies against evolving viral threats includin...

Waltham, United States51–200healthtech, Biotech
Funding undisclosed
Spring Health

Mental health benefits platform for employers and health plans that uses precision mental healthc...

New York, United States1001–5000Healthcare, SaaS
Series E·$465.0M·Jul 2024
ArvinasIPO

Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurode...

New Haven, United States201–500Biotech, Healthcare
Private Equity·$464.9M·Nov 2023
HeartFlowIPO

Heartflow’s vision is to transform CAD from the leading cause of death into a disease that can be...

San Francisco, United States501–1000Healthcare, healthtech
Convertible·$464.6M·Mar 2025
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series D·$461.5M·Jul 2022
Nektar TherapeuticsIPO

Research-based development stage biopharmaceutical company that discovers and develops innovative...

San Francisco, United States51–200biotech, immunotherapy
Corporate Round·$460.0M·Feb 2026
Virta Health

Telehealth company delivering a clinically-proven treatment to reverse type 2 diabetes and other ...

San Francisco, United States201–500Chronic Disease, Digital Health
Series E·$459.0M·Apr 2021
Vicarious SurgicalIPO

Vicarious Surgical improves the lives of patients and surgeons by giving access to high quality c...

Boston, United States51–200Hardware, Healthcare
Corporate Round·$457.6M·Oct 2025
Paras PharmaClosed

Healthcare and personal care products manufacturer and distributor

Ahmedabad, India201–500Healthcare
Corporate Round·$457.4M·Dec 2010
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Unknown·$453.5M·Jan 2026
Capital Rx

Full-service pharmacy benefits manager and administrator serving employers and health plans with ...

New York City, United States501–1000Life Sciences, Healthcare
Series F·$452.3M·Sep 2025
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, GI Health
Venture Unknown·$450.3M·May 2023
LetsGet Checked

Providing tools to manage health from home

Dublin, Ireland501–1000Diagnostics, Healthcare
Series F·$448.0M·Jan 2025
US Heart & Vascular

Cardiovascular value-based care support services

Franklin, United States1001–5000Health Services, Healthcare
Growth Equity·$446.0M·May 2023
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series C·$435.0M·Jun 2021
Verve TherapeuticsAcquired

Develops one-time in vivo gene-editing medicines to prevent and treat atherosclerotic cardiovascu...

Boston, United States201–500Biotech, Drug Discovery
Series C·$428.5M·Oct 2024
BioNTech

German biotech company developing mRNA-based immunotherapies and vaccines.

Mainz, Germany5001–10000Biotech, Healthcare
Series A·$425.0M·Jan 2019
Transcarent

Transcarent is the One Place for Health and Care that makes it easy for people to access high-qua...

San Francisco, United StatesLife Sciences, Artificial Intelligence
Series D·$424.0M·May 2024
Angitia Biopharmaceuticals

Clinical-stage biotech developing novel bispecific antibody therapies for musculoskeletal and bon...

Westlake Village, United States51–200Biotech, Healthcare
Series D·$420.0M·Feb 2026
Medable

Medable provides a leading global cloud platform for decentralized clinical trials (DCT), offerin...

Palo Alto, United States501–1000Healthcare, SaaS
Series D·$420.0M·Oct 2021
Benchling

Unlocking the power of biotech with modern software for modern science

San Francisco, United States501–1000Biotech, SaaS
Series F·$412.0M·Nov 2021
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series C·$407.3M·Feb 2025
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Diagnostics, Genomics
Venture Unknown·$406.0M·Mar 2026
AlayaCare

AlayaCare is a provider of cloud-based home health care software for agencies worldwide.

Montreal, Canada501–1000Digital Health, Healthcare
Growth Equity·$405.8M·Feb 2026
Athelas

Digital tools for healthcare providers

Mountain View, United States51–200Biotech, Healthcare
Growth Equity·$404.0M·Jun 2025